Neurogenic Bladder

0
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

ConvaTec
ConvaTecNJ - Bridgewater
1 program
Intermittent self-catheterisationN/A1 trial
Active Trials
NCT05683938CompletedEst. Apr 2023
C
ColoplastAustralia - Mulgrave
1 program
Peristeen Transanal IrrigationN/A1 trial
Active Trials
NCT04815226UnknownEst. Dec 2023
Connect Biopharma
Connect BiopharmaSAN DIEGO, CA
1 program
Vivally system stimulationN/A
Mission Therapeutics
Mission TherapeuticsUK - Cambridge
1 program
Vivally system stimulationN/A1 trial
Active Trials
NCT06661057Withdrawn0Est. Nov 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Mission TherapeuticsVivally system stimulation
ConvaTecIntermittent self-catheterisation
ColoplastPeristeen Transanal Irrigation

Clinical Trials (3)

NCT06661057Mission TherapeuticsVivally system stimulation

Avation Electric Stimulation System for Spinal Cord Injury Neurogenic Bladder

Start: Dec 2024Est. completion: Nov 20260
N/AWithdrawn
NCT05683938ConvaTecIntermittent self-catheterisation

GentleCath™ Air Intermittent Catheter Smartwatch Real Life Pilot Study

Start: Nov 2021Est. completion: Apr 2023
N/ACompleted
NCT04815226ColoplastPeristeen Transanal Irrigation

The Role of Active Administration of Peristeen Bowel Evacuation for the Management of Urinary Tract Infection

Start: Apr 2021Est. completion: Dec 2023
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space